NCT04318509View on ClinicalTrials.gov

Market Research - Acceptability Study for a New PKU Protein Substitute

NACompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

February 4, 2019

Primary Completion Date

May 19, 2019

Study Completion Date

May 19, 2019

Conditions
PKUPhenylketonuriasInborn Errors of MetabolismMetabolic Disease
Interventions
DIETARY_SUPPLEMENT

GMPOWER

(casein) glycomacropeptide protein substitute for the dietary management of PKU from the age of 3 years

Trial Locations (2)

B4 6NH

Birmingham Children's Hospital, Birmingham

BS2 8BJ

Bristol Royal Hospital for Children, Bristol

All Listed Sponsors
lead

Dr. Schär AG / SPA

INDUSTRY

NCT04318509 - Market Research - Acceptability Study for a New PKU Protein Substitute | Biotech Hunter | Biotech Hunter